Resumed Buy X

ACET Adicet Bio

Guggenheim

$7

Downgrades Buy Neutral X

ACET Adicet Bio

H.C. Wainwright

Downgrades Buy Neutral X

ACET Adicet Bio

Guggenheim

Downgrades Mkt Outperform Mkt Perform X

ACET Adicet Bio

JMP Securities

Downgrades Overweight Neutral X

ACET Adicet Bio

JP Morgan

$20 $6

Initiated Overweight X

ACET Adicet Bio

JP Morgan

$23

Initiated Outperform X

ACET Adicet Bio

SMBC Nikko

$28

Initiated Buy X

ACET Adicet Bio

Truist

$30

Initiated Buy X

ACET Adicet Bio

BTIG Research

$34

Initiated Buy X

ACET Adicet Bio

H.C. Wainwright

$27

Initiated Buy X

ACET Adicet Bio

Canaccord Genuity

$28

Initiated Buy X

ACET Adicet Bio

Guggenheim

$22

ACET  Aceto Corporation

Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. As of June 30, 2016, it distributed over 1,100 chemical compounds used primarily as finished products or raw materials in the agricultural, coatings and industrial chemical industries. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. As of June 30, 2016, the Pharmaceutical Ingredients segment had two product groups: Active Pharmaceutical Ingredients and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products.